Show simple item record

dc.contributor.authorUyguner, Zehra
dc.contributor.authorTETİK, ŞERMİN
dc.contributor.authorAK, KORAY
dc.contributor.authorAhmad, Sarfraz
dc.contributor.authorYardimci, K.
dc.contributor.authorAltinoz, Hilal
dc.contributor.authorErgun, Ilyas
dc.date.accessioned2021-03-05T17:50:03Z
dc.date.available2021-03-05T17:50:03Z
dc.identifier.citationAltinoz H., Ergun I., AK K., Uyguner Z., Ahmad S., Yardimci K., TETİK Ş., "Evaluation of platelet GPIIb rs5911 polymorphism in relation to inflammation in patients with chronic obstructive pulmonary disease", INDIAN JOURNAL OF BIOCHEMISTRY & BIOPHYSICS, cilt.52, ss.289-296, 2015
dc.identifier.issn0301-1208
dc.identifier.othervv_1032021
dc.identifier.otherav_c7742ea8-dd98-4403-8694-481382c77be3
dc.identifier.urihttp://hdl.handle.net/20.500.12627/132213
dc.description.abstractChronic obstructive pulmonary disease (COPD) has susceptibility to inflammation, and hence demands investigation for/on its association with systemic inflammatory cytokines. Here, we evaluated platelet GPIIb rs5911 polymorphism and its relevance to inflammation in COPD patients using biomarkers. The study enrolled COPD patients (n=40) from S B Sureyyapasa Thoracic Disease Research & Training Hospital during May 2009 to December 2011 and healthy volunteers (n=24) from the Faculty of Pharmacy Laboratories, Marmara University, Istanbul, Turkey. Patient demographics, smoking habits, duration of COPD, co-morbidities, hemogram, C-reactive protein, biochemical and spirometry data were collected. Biomarker's levels were quantitated by ELISA. After DNA isolation, GPIIb/Ilia and GPUb polymorphisms were determined by PCR-RFLP, and gel electrophoresis to determine ITGA2B rs5911 polymorphism. Mean age was: patients=60.3 +/- 11.8 years and controls=51.4 +/- 7.0 years. There was significant difference in patient's disease periods (acute 9.8 +/- 6.9 vs. stable 1.6 +/- 1.1 years, P <0.05). 70% COPD patients had co-morbidities. Patients vs. control levels were: IL-6 (148.4 +/- 18.4 vs. 139.6 +/- 16.3 pg/mL; P =0.60), IL-10 (119.5 +/- 30.2 vs. 106.5 +/- 13.9 pg/mL; P =0.44), TNF-a (483.8 63.7 vs. 447.3 +/- 46.3 pg/mL; P =0.018). IL-6 and IL-10 levels were found decreased while hemoglobin, hematocrit, leukocyte, platelet count increased. Similarly, TNF-a also decreased while hematocrit and leukocyte increased (as the platelet counts also increased). Patient's genotypes were 41.5% T/T (homolog-normal), 38.9% T/G (heterolog-polymorphic), 19.4% G/G (homolog-polymorphic), and control's 33.3% T/T, 60% T/G, 6.7% G/G. While the T/T genotype patients were younger with longer COPD duration, G/G genotype cases were older, less smoker, and less hypertensive. The G/G genotype cases had more IL-10 vs. T/T cases. G/G genotype patients were older compared to others. Over all, the systemic inflammatory cytokine levels were relatively higher in COPD patients suggesting inflammatory response. Despite less smoking, G/G homolog polymorphism showed susceptibility to inflammation.
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectTemel Tıp Bilimleri
dc.subjectBiyofizik
dc.subjectBiyokimya
dc.subjectYaşam Bilimleri
dc.subjectMoleküler Biyoloji ve Genetik
dc.subjectSitogenetik
dc.subjectTemel Bilimler
dc.subjectBiyoloji ve Biyokimya
dc.subjectTıp
dc.subjectBİYOFİZİK
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectMoleküler Biyoloji ve Genetik
dc.subjectBİYOKİMYA VE MOLEKÜLER BİYOLOJİ
dc.titleEvaluation of platelet GPIIb rs5911 polymorphism in relation to inflammation in patients with chronic obstructive pulmonary disease
dc.typeMakale
dc.relation.journalINDIAN JOURNAL OF BIOCHEMISTRY & BIOPHYSICS
dc.contributor.departmentAcibadem Hospitals Group , ,
dc.identifier.volume52
dc.identifier.startpage289
dc.identifier.endpage296
dc.contributor.firstauthorID225258


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record